Repurposing Atomoxetine for Neuroprotection in MCI Repurposing Atomoxetine for Neuroprotection in MCI

Atomoxetine, approved for ADHD, can be repurposed as a safe and effective therapy for mild cognitive impairment and improves multiple biomarkers of Alzheimer ' s disease, according to this study.Brain
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news